Bristol-Myers Squibb Company (BMY)
NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous Close | 48.86 |
| Open | 47.39 |
| Bid | 44.74 x 1000 |
| Ask | 44.79 x 1400 |
| Day's Range | 44.37 - 47.50 |
| 52 Week Range | 44.37 - 69.10 |
| Volume | |
| Avg. Volume | 15,456,937 |
| Market Cap | 90.596B |
| Beta (5Y Monthly) | 0.39 |
| PE Ratio (TTM) | 11.58 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | 2.40 (4.91%) |
| Ex-Dividend Date | Apr 04, 2024 |
| 1y Target Est | N/A |
- Investor's Business Daily
AstraZeneca Flirts With A Breakout After Cancer Drug Sales Shine; Sanofi, Bristol Stocks Diverge
AstraZeneca stock bolted higher Thursday — and is now within striking distance of a breakout — after its cancer drugs propelled a sales beat.
- Zacks
Biotech Stock Roundup: BIIB, BMY's Q1 Earnings, INCY's Acquisition & Updates from VRTX
Biogen (BIIB) and Bristol Myers (BMY) are in focus following Q1 earnings announcement.
- Zacks
Bristol Myers (BMY) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates (Revised)
While the top- and bottom-line numbers for Bristol Myers (BMY) give a sense of how the business performed in the quarter ended March 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
© 2024 Yahoo. All rights reserved.